Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
It competes with sulfate-reducing bacteria for resources, effectively crowding them out over time
Mounjaro is a dual GIP/GLP-1 receptor agonist while Ozempic only targets the GLP-1 receptor, thereby providing better blood sugar control
New England Journal of Medicine , 335(1), 1-7
Safety profile In the overall population from SURMOUNT-5, 2 (0.3%) self-reported adverse events of T2D were reported, one in each treatment arm
I am proud to have recently earned my certification from the American Board of Obesity Medicine , adding to my expertise in Gastroenterology and Internal Medicine
This could be among the first next-generation approvals, potentially in 20252026
